{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-001999","form_type":"8-K","ticker":"CNBX","cik":"0001343009","company_name":"CNBX Pharmaceuticals Inc.","filed_at":"2022-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.059579+00:00","generated_at":"2026-06-26T15:52:20.449878+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Cannabics Pharmaceuticals changes name to CNBX Pharmaceuticals, ticker unchanged","bullets":["Name change effective March 28, 2022; stock continues trading on OTCQB under symbol CNBX.","Name change reflects transformation to molecule-based drug development for colorectal cancer treatment.","Company preparing Phase I/II clinical validation study for proprietary RCC-33 drug candidate.","Stockholders need not exchange certificates; rights unaffected."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-001999","json":"https://secwatch.observer/filing/0001683168-22-001999.json","markdown":"https://secwatch.observer/filing/0001683168-22-001999.md","text":"https://secwatch.observer/filing/0001683168-22-001999.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1343009/000168316822001999/0001683168-22-001999-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1343009/000168316822001999/cannabics_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T15:52:20.449878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}